Universal-Beteiligungs- und Servicegesellschaft’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
16,734
-10,759
-39% -$691K ﹤0.01% 1474
2026
Q1
$1.55M Buy
27,493
+13,022
+90% +$848K ﹤0.01% 1337
2025
Q4
$1.17M Buy
14,471
+7,958
+122% +$535K ﹤0.01% 1445
2025
Q3
$317K Buy
6,513
+2,038
+46% +$126K ﹤0.01% 1886
2025
Q2
$334K Sell
4,475
-21,737
-83% -$1.44M ﹤0.01% 1800
2025
Q1
$1.67M Buy
+26,212
New +$1.78M ﹤0.01% 1281

Other funds holding HAE

Universal-Beteiligungs- und Servicegesellschaft's HAE Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Haemonetics (HAE) stake by 39% in Q2 2026, selling an estimated $691K and leaving 16,734 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in HAE in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.67M in Q1 2025. 229 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 16,734 shares of Haemonetics worth $1.26M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 10,759 Haemonetics shares in Q2 2026, an estimated $691K.
  • Haemonetics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1474 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Haemonetics in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Haemonetics position peaked at $1.67M in Q1 2025.
  • 229 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.